CMP Pharma Releases Liqrev, First FDA-Approved Liquid Suspension of Sildenafil

CMP Pharma, a pharmaceutical manufacturer, announced that Liqrev, the first FDA-approved ready-made oral liquid of sildenafil, is now available. Created for patients with the inability to swallow tablets, the medication is designated for the treatment of pulmonary arterial hypertension.

"Liqrev is for patients who need a liquid formulation because they have difficulty swallowing tablets. This product is a nice addition to our portfolio of liquids for patients with pulmonary arterial hypertension (PAH)," said Gerald Sakowski, CEO, CMP Pharma, Inc.

Reference: CMP Pharma, Inc Announces that Liqrev®, the First and Only Ready-made FDA-approved Liquid Suspension of Sildenafil is Now Available. PR Newswire. June 21, 2023. Accessed June 22, 2023. https://www.prnewswire.com/news-releases/cmp-pharma-inc-announces-that-liqrev-the-first-and-only-ready-made-fda-approved-liquid-suspension-of-sildenafil-is-now-available-301856229.html